DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
This Quarter Return
+3.04%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$118M
AUM Growth
+$118M
Cap. Flow
-$17.6M
Cap. Flow %
-14.86%
Top 10 Hldgs %
43.16%
Holding
93
New
21
Increased
10
Reduced
13
Closed
18

Top Buys

1
ABBV icon
AbbVie
ABBV
$7.83M
2
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2.64M
3
XNPT
XENOPORT, INC.
XNPT
$2.54M
4
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
$2.11M
5
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$1.73M

Top Sells

1
PCYC
PHARMACYCLICS INC
PCYC
$18.3M
2
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$12.1M
3
MTEM
Molecular Templates, Inc.
MTEM
$2.54M
4
ATRC icon
AtriCure
ATRC
$2.19M
5
MASI icon
Masimo
MASI
$774K

Sector Composition

1 Healthcare 73.78%
2 Financials 0.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ATRC icon
1
AtriCure
ATRC
$1.84B
$13.5M 11.43% 548,611 -88,820 -14% -$2.19M
ABBV icon
2
AbbVie
ABBV
$372B
$7.83M 6.62% +116,581 New +$7.83M
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
$5.24M 4.43% 366,554 – –
ACHN
4
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$4.26M 3.6% 480,300 +238,700 +99% +$2.11M
RIGL icon
5
Rigel Pharmaceuticals
RIGL
$697M
$3.56M 3.01% 1,109,740 – –
ZSPH
6
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$3.52M 2.97% 67,100 +28,000 +72% +$1.47M
BCRX icon
7
BioCryst Pharmaceuticals
BCRX
$1.74B
$3.31M 2.8% 221,656 +55,000 +33% +$821K
PODD icon
8
Insulet
PODD
$23.9B
$3.29M 2.78% 106,018 – –
WINT
9
DELISTED
Windtree Therapeutics Inc
WINT
$3.26M 2.76% 4,794,874 -35,000 -0.7% -$23.8K
XNPT
10
DELISTED
XENOPORT, INC.
XNPT
$3.26M 2.75% 531,032 +414,773 +357% +$2.54M
AERI
11
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$2.77M 2.34% 156,842 -3,400 -2% -$60K
DSCI
12
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$2.68M 2.26% 373,918 – –
SGYP
13
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2.64M 2.23% +317,563 New +$2.64M
EPIX icon
14
ESSA Pharma
EPIX
$11.4M
$2.63M 2.22% 231,200 -18,800 -8% -$214K
OTIC
15
DELISTED
Otonomy, Inc.
OTIC
$2.56M 2.17% 111,466 +61,466 +123% +$1.41M
AGTC
16
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.41M 2.04% 157,192 +47,869 +44% +$734K
PLX icon
17
Protalix BioTherapeutics
PLX
$124M
$2.4M 2.03% 1,230,789 – –
BEAT
18
DELISTED
BioTelemetry, Inc.
BEAT
$2.22M 1.88% 235,645 – –
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
$2.03M 1.72% 23,090 -310 -1% -$27.2K
STXS icon
20
Stereotaxis
STXS
$261M
$1.98M 1.67% 1,372,862 – –
MASI icon
21
Masimo
MASI
$7.59B
$1.78M 1.51% 46,010 -19,990 -30% -$774K
CYNA
22
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$1.73M 1.46% +94,824 New +$1.73M
EVFM
23
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1.66M 1.4% 184,187 -2,620 -1% -$23.6K
ASND icon
24
Ascendis Pharma
ASND
$11.8B
$1.65M 1.4% 93,541 – –
CYAD
25
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$1.56M 1.32% +30,000 New +$1.56M
1
2 3 4